Breaking Research News from Breastcancer.org
Comments
-
Low-Fat Diet and Weight Loss Improves Survival in Some Women
December 16, 2014
Eating a low-fat diet and losing weight improved survival in women diagnosed with early-stage, hormone-receptor-negative breast cancer. Read more...0 -
Male Breast Cancer Is Different in Terms of Biology and Outcomes
December 17, 2014
While survival for men diagnosed with breast cancer has improved, it hasn't kept up with the improvements in survival for women with breast cancer. Read more...0 -
Abraxane Offers More Benefits Than Taxol When Given Before Surgery to Treat Early-Stage Disease
December 18, 2014
Abraxane offers better pathologic complete response rates than Taxol when given before surgery to treat early-stage breast cancer. Read more...0 -
Tamoxifen's Benefits Long-Lasting for High-Risk Women
December 19, 2014
The hormonal therapy medicine tamoxifen continues to reduce risk in high-risk women who haven't been diagnosed more than 10 years after they stop taking it. Read more...0 -
Faslodex Offers Better Survival Than Arimidex as First Treatment for Women With Advanced-Stage Disease
December 23, 2014
A study has found that using Faslodex as the first treatment for hormone-receptor-positive, advanced-stage breast cancer offers better survival than using Arimidex as the first treatment. Read more...0 -
Oncotype DX DCIS Test Helps Predict Risk of Recurrence
December 29, 2014
The Oncotype DX DCIS test helped predict the risk of DCIS recurrence, which can help women and their doctors make decisions about treatments after surgery. Read more...0 -
Certain Benign Breast Disease Increases Risk More Than Thought
January 6, 2015
A study has found that women diagnosed with atypical hyperplasia, a type of benign breast disease, have a higher risk of developing breast cancer than doctors previously thought. Read more...0 -
Herceptin Plus Taxol Reduces Recurrence Risk of Small HER2-Positive Breast Cancers
January 9, 2015
Results from an early study suggest that a combination of Herceptin and Taxol reduce the risk of recurrence of small HER2-positive breast cancers that haven't spread to the lymph nodes. Read more...0 -
Dear Moderators
When i was DX Herceptin was just approved for early stage BC
I was one of the first patient got it with Taxol
It's good to read your link
Sheila
0 -
New Gene Seems Especially Active in Triple-Negative Breast Cancer
January 21, 2015
A study has found a new gene that is especially active in triple-negative breast cancer and seems to drive its growth and spread. Read more...0 -
Use of Shorter Radiation Regimen Triples, but Still Underused Experts Say
January 24, 2015
More U.S. women diagnosed with early-stage breast cancer were treated after lumpectomy with a whole-breast radiation schedule that was shorter than the conventional regimen, but this shorter schedule still wasn't prescribed as often as it could be. Read more...0 -
Mods could you check the figures comparing the costs for group one and group two? There is a mixup. It doesn't make sense that the costs of radiation, whatever the regime, short or conventional, is more than double for the women under age 50, had chemo, or had positive nodes.
Btw how come this research was not picked up as something of interest to me based on my treatment profile?0 -
High Levels of Immune Cells in HER2-Positive Cancers May Mean Tumors Need Only Chemotherapy
January 30, 2015
A study suggests that HER2-positive breast cancer tumors with high levels of tumor-infiltrating lymphocytes had a lower risk of the cancer coming back when treated with chemotherapy alone compared to HER-positive tumors with low levels of tumor-infiltrating lymphocytes treated with only chemotherapy. Read more...0 -
Risk of Leukemia After Chemotherapy or Radiation Therapy for Early-Stage Breast Cancer Higher Than Thought
February 3, 2015
While the risk of developing leukemia after radiation therapy or chemotherapy to treat early-stage breast cancer is VERY small, a large study suggests that this risk is twice as high as has been reported. Read more...0 -
Palbociclib (Also Called Ibrance) Approved by FDA
February 4, 2015
The FDA has granted accelerated approval for using the targeted therapy Ibrance in combination with Femara to treat advanced-stage, estrogen-receptor-positive, HER2-negative breast cancer that hadn't been treated with hormonal therapy before in postmenopausal women. Read more...0 -
Breast Cancer Stage at Diagnosis, Survival Rates Varies by Race, Ethnicity
February 8, 2015
A study suggests that the differences in stage at diagnosis and survival rates among racial/ethnic groups are because of the biological characteristics of the cancers. Read more...0 -
Halaven No Better Than Xeloda for Previously Treated Metastatic Disease
February 9, 2015
A study has found that Halaven offers the same benefits as Xeloda for women diagnosed with metastatic disease that already has been treated with an anthracycline and a taxane. Read more...0 -
Ultrasound After Chemotherapy Before Surgery Can Help Doctors Decide How Many Lymph Nodes to Remove
February 12, 2015
A study suggests that using ultrasound to see if the axillary lymph nodes have cancer in them can help doctors decide which women diagnosed with node-positive breast cancer treated with chemotherapy before surgery are good candidates for sentinel lymph node surgery. Read more...0 -
Many Women Diagnosed With Breast Cancer Know Little About Their Condition
February 12, 2015
A study has found that a large number of women diagnosed with breast cancer know little about the basic characteristics of the cancer, including its stage, its estrogen-receptor status, its grade, and its HER2 status. Read more...0 -
New Model Offers Better Breast Cancer Risk Estimate for Black Women
February 16, 2015
Researchers have developed a new breast cancer risk prediction model for black women that is more accurate than the traditional Gail model. Read more...0 -
New Genetic Abnormalities Linked to Breast Cancer in Black Families
February 17, 2015
A study has discovered DNA abnormalities shared by black family members who have been diagnosed with breast cancer. These abnormalities could lead to the discovery of gene mutations linked to breast cancer that are unique to blacks. Read more...0 -
Many Women Don't Get Recommended Radiation After Mastectomy to Remove Locally Advanced Disease
February 17, 2015
A study found that many women diagnosed with breast cancer that has spread to four or more lymph nodes don't get radiation therapy after mastectomy, even though oncology guidelines recommend it. Read more...0 -
Mammogram Rates Declined 3 Years After Unadopted Task Force Recommendations
February 18, 2015
Research has found that fewer women got screening mammograms 3 years after a task force recommended that screening mammograms start at age 50 instead of 40. Read more...0 -
Household Net Worth Has Big Effect on Whether Women Finish Hormonal Therapy Treatment
February 24, 2015
A study has found that household net worth has a big effect on whether women will stick to their hormonal therapy treatment plans. Read more...0 -
Chemotherapy Before Surgery Increases Likelihood of Lumpectomy
March 4, 2015
Yale University researchers found that women with larger breast cancers who had chemotherapy before surgery were more likely to have lumpectomy than mastectomy. Read more...0 -
Zoladex Helps Preserve Fertility in Women Diagnosed With Early-Stage, Hormone-Receptor-Negative Disease After Chemotherapy
March 5, 2015
Research shows that premenopausal women diagnosed with hormone-receptor-negative, early-stage breast cancer who were treated with Zoladex and chemotherapy were much less likely to be infertile. Read more...0 -
Oncotype DX Test Adopted Quickly, Used Appropriately
March 5, 2015
Research shows the Oncotype DX test to assess the recurrence risk of early-stage, estrogen-receptor-positive breast cancer was quickly adopted and that it's being used as recommended by guidelines. Read more...0 -
Family History of Prostate Cancer Seems to Increase Breast Cancer Risk
March 13, 2015
A study suggests that women with first-degree relatives who have been diagnosed with prostate cancer probably have a higher risk of breast cancer. Read more...0 -
Herceptin Plus Chemotherapy Better Than Tykerb Plus Chemotherapy as First Treatment for Metastatic HER2-Positive Disease
March 18, 2015
A study has found that treating newly diagnosed HER2-positive, metastatic breast cancer with a combination of chemotherapy and Herceptin offers more benefits than Tykerb plus chemotherapy as a first treatment. Read more...0 -
Study Looks at Accuracy of Breast Biopsy Results
March 18, 2015
A study looked at the accuracy of pathologists' interpretations of breast biopsies. The results have generated some controversy. Read more...0
